Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
201K
-
Shares change
-
-14.1K
-
Total reported value, excl. options
-
$1.32M
-
Value change
-
-$124K
-
Put/Call ratio
-
0.51
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$6.65
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q1 2016
28 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q1 2016.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 201K shares
of 41M outstanding shares and own 0.49% of the company stock.
Largest 10 shareholders include TOCQUEVILLE ASSET MANAGEMENT L.P. (70K shares), BARCLAYS PLC (29.9K shares), Cutler Group LP (19.6K shares), HSBC HOLDINGS PLC (15K shares), PNC Financial Services Group, Inc. (13.8K shares), GREYLIN INVESTMENT MANGEMENT INC (10.3K shares), WELLS FARGO & COMPANY/MN (10.1K shares), GROUP ONE TRADING, L.P. (10K shares), MORGAN STANLEY (3.81K shares), and FineMark National Bank & Trust (3.47K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.